Scientists test new 'Cancer Spotlight' imaging method
NCT ID NCT07132645
Summary
This early study is testing a new radioactive tracer called [68Ga]Ga-FAPI-04 to see where it collects in the body of patients with aggressive neuroendocrine tumors. Researchers will use PET/CT scans to measure how much of the tracer accumulates in tumors compared to normal tissues. The goal is to understand if this tracer could help doctors better see and understand these cancers through imaging.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan Comprehensive Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.